Skip to main content

Table 2 Adverse events reported during the studies

From: Development and evaluation of a new Plasmodium falciparum 3D7 blood stage malaria cell bank for use in malaria volunteer infection studies

Adverse event 3D7-V1 (N = 2) n (M) 3D7-MBE-008 (N = 2) n (M)
Systemic
 Arthralgia 2 (2) 0 (0)
 Chills 2 (3) 2 (3)
 Decreased appetite 1 (1) 1 (1)
 Fatigue 1 (2) 0 (0)
 Feeling hot 1 (1) 1 (1)
 Headache 2 (3) 2 (3)
 Lethargy 0 (0) 1 (1)
 Malaise 1 (1) 0 (0)
 Myalgia 2 (3) 2 (4)
 Pyrexia 2 (2) 2 (3)
 Sweating 2 (2) 1 (3)
 Tachycardia 1 (1) 1 (2)
Laboratory abnormalities
 ALT increased 1 (1) 1 (1)
 AST increased 0 (0) 1 (1)
 Lymphocyte count decreased 1 (1) 2 (1)
 Neutrophil count decreased 0 (0) 1 (1)
Gastrointestinal
 Abdominal pain 0 (0) 2 (2)
 Constipation 0 (0) 1 (1)
 Diarrhoea 0 (0) 2 (2)
Other
 Back pain 0 (0) 1 (1)
 Erythema (from tape) 0 (0) 1 (1)
 Pain (venepuncture site) 0 (0) 1 (1)
 Ulcer (lip) 0 (0) 1 (1)
 Upper respiratory tract infection 1 (1) 0 (0)
  1. N, total number of participants in each cohort; n, number of participants reporting the adverse event; M, number of occurrences of adverse events. Adverse events were coded to System Organ Class and Preferred Term using MedDRA Version 20.1
\